The zebrafish hoxd4a locus was compared to its murine ortholog, Hoxd4. The sequence of regulatory elements, including a DR5 type retinoic acid response element (RARE) required for Hoxd4 neural enhancer activity, are highly conserved. Additionally, zebrafish and mouse neural enhancers function identically in transgenic mouse embryos. We tested whether sequence conservation reflects functional importance by altering the spacing and sequence of the RARE in the Hoxd4 neural enhancer. Stabilizing receptor-DNA interactions did not anteriorize transgene expression. By contrast, conversion of the RARE from a DR5 to a DR2 type element decreased receptor-DNA stability and posteriorized expression. Hence, the setting of the Hox anterior expression border is not a simple function of the affinity of retinoid receptors for their cognate element. q
Introduction
Hox genes code for transcription factors that assign positional identity along the embryonic anterior-posterior (AP) axis. In mammals, 39 genes are organized into four clusters. Expression is tightly regulated within these clusters such that genes located at more 3 0 positions are expressed earlier and more anteriorly. The anterior border of a given Hox expression domain partially determines positional identity since a rostral shift in this border results in homeotic transformations (Lufkin et al., 1992; McLain et al., 1992; Zhang et al., 1994) . In addition, defects are often restricted to the anterior end of the expression domain following the loss of Hox expression (Chisaka and Capecchi, 1991; Chisaka et al., 1992; Horan et al., 1995a, b; Lufkin et al., 1991; Ramírez-Solis et al., 1993) . Therefore, the setting of the correct anterior border of expression for each Hox gene is crucial for normal patterning.
A large body of data demonstrates that endogenous retinoids regulate Hox gene expression. In vitro the addition of RA induces Hox gene expression in a time-and dosedependent manner (Papalopulu et al., 1991; Simeone et al., 1990) . In vivo RA exposure during specific gestational windows provokes vertebral homeotic transformations (Kessel and Gruss, 1991) that coincide with the anteriorization of Hox expression domains (Conlon, 1995; Kessel and Gruss, 1991) . In the hindbrain, RA-induced anteriorization of Hox expression (Conlon and Rossant, 1992) results in altered rhombomere (r) identity (Marshall et al., 1992) . For several Hox genes, the response to RA is directly mediated by the presence of a retinoic acid response element (RARE) found 5 0 and/or 3 0 to the coding regions (Dupé et al., 1997; Gérard et al., 1996; Gould et al., 1998; Huang et al., 2002; Marshall et al., 1994; Studer et al., 1994 Studer et al., , 1998 Zhang et al., 2000) . These RAREs are composed of two direct repeats (DRs) separated by a 2 or 5 nucleotide spacer, and are bound by heterodimers composed of one retinoid X receptor (RXRs a, b, and g) and one retinoic acid receptor (RARs a, b, and g) (Mangelsdorf et al., 1995) . DNA-bound heterodimers act as ligand-inducible transcriptional regulators (Kastner et al., 1997) . Disruption of multiple retinoid receptor genes cause malformations, some of which are homeotic transformations (Kastner et al., 1997; Lohnes et al., 1993 Lohnes et al., , 1994 . In the hindbrain, RAREs direct expression of at least four Hox genes. Mutation of the Hoxa1 RARE (Frasch et al., 1995) , Hoxb1 RARE , Hoxb4 RARE (Gould et al., 1998) and Hoxd4 RARE (Zhang et al., 2000) all result in reduction or loss of reporter expression in the developing CNS, and abolish transgene responsiveness to RA treatment. Gene targeted mutation of either the Hoxa1 RARE or Hoxb1 RARE results in lower expression of the cognate gene in the hindbrain, and perturbs the normal development of this region (Dupé et al., 1997; Studer et al., 1998) . Replacement of the Hoxb4 DR5 RARE by the Hoxb1 DR2 RARE anteriorizes transgene activity within the hindbrain (Gould et al., 1998) , a tissue requiring RARa and RARb for Hox gene expression (Blumberg et al., 1997; Dupé et al., 1999; Folberg et al., 1999) . Hence the nature of the RARE, as well as the specific receptors which bind it, may be important in setting Hox gene expression domains.
Experimental evidence supports the presence of a RA gradient in the hindbrain (Dupé and Lumsden, 2001; Gavalas and Krumlauf, 2000; Maden et al., 1998) . This gradient appears to be established by the opposing actions of two enzymes. The Raldh2 gene product converts retinaldehyde into RA and is strongly expressed in the cervical mesenchyme surrounding the spinal cord (Niederreither et al., 1997; Zhao et al., 1996) . Cyp26A1, whose product oxidatively inactivates RA, is expressed in the fore-and midbrain regions of the neural plate and in r2 (Fujii et al., 1997; MacLean et al., 2001 ). Cyp26B1, a homolog of Cyp26A1, is expressed in r3 and r5 at 8.0 dpc (MacLean et al., 2001 ). By 9.5 dpc, Cyp26B1 is strongly active in r5 and r6, and weakly in the basal area of r2, r3, and r4 (MacLean et al., 2001 ). The expression of these genes may establish a gradient of RA between the caudal (high) and rostral (low) hindbrain (Dupé and Lumsden, 2001; Maden et al., 1998) and may establish the expression domains of RA-responsive Hox genes. Hox genes that are induced by RA at lower concentrations in vitro (Papalopulu et al., 1991; Simeone et al., 1990 ) have more anterior borders than those requiring higher concentrations. Therefore, the spatial regulation of genes responsible for hindbrain patterning may be regulated by the local accumulation of RA (Dupé and Lumsden, 2001; Niederreither et al., 2000) .
Transgenic analysis of murine Hoxb4 reveals that a region 3 0 to the transcription unit directs b-galactosidase expression with the same mesodermal and neurectodermal anterior boundaries as observed for the endogenous gene (Whiting et al., 1991) . A similar regulatory region is found downstream of the coding exons of the murine Hoxd4 gene Zhang et al., 1997) . Additional transgenic analysis has more finely mapped a Hoxd4 neural enhancer, and identified a DR5 type RARE absolutely required for activity (Zhang et al., 2000) .
Other elements have been identified that control Hoxd4 expression. These include an autoregulatory element (ARE), a 5 0 RARE, and two promoters (P1 and P2; Folberg et al., 1997) . The Hoxd4 ARE and 5 0 RARE were characterized in P19 embryonal carcinoma cells Featherstone, 1992, 1993) , and the latter may contribute to somitic Hoxd4 expression (Zhang et al., 1997) . The ARE contains two HOX binding sites (TAAT) that are required for reporter activity and are bound by HOXD4 protein (Pöpperl and Featherstone, 1992) . In addition, transgenic analysis reveals two regions controlling mesodermal expression of Hoxd4. A 5 0 mesodermal enhancer directs expression in the paraxial and lateral plate mesoderm, while a 3 0 mesodermal enhancer is responsible for setting the anterior border in the paraxial mesoderm Zhang et al., 1997) .
A number of studies have made use of phylogenetic comparisons to map conserved regulatory elements required for Hox expression (Aparicio et al., 1995; Marshall et al., 1994; Morrison et al., 1995; Müller et al., 2002; Pöpperl et al., 1995; Studer et al., 1994) . We have cloned and sequenced the zebrafish hoxd4a gene in order to identify such elements. We find that the sequence of the two RAREs, the P1 promoter, a presumptive intron enhancer, and the ARE are highly conserved. We also observe large regions of highly homologous sequence preceding the transcription and translation start sites. Since the 3 0 RARE is a crucial component of the murine Hoxd4 neural enhancer (Zhang et al., 2000) , we tested the importance of its sequence and spacing, two features highly conserved with zebrafish. We measured the half-life of RXRa·RARa heterodimers for different RAREs and tested these RAREs in the context of a Hoxd4 neural enhancer transgene. Conversion to a consensus RARE increased heterodimer stability but failed to anteriorize transgene expression beyond the r6/7 border. On the other hand, changing the RARE into a DR2 element decreased heterodimer stability, and reduced and posteriorized transgene expression into the spinal column. Therefore, we find that the setting of the anterior border of Hoxd4 expression is not solely determined by RXR·RAR heterodimer affinity since changes to the RARE that increase heterodimer-DNA stability cannot anteriorize transgene expression beyond the r6/7 border in the hindbrain.
Results
2.1. The sequence of several regulatory elements are conserved between mouse Hoxd4 and zebrafish hoxd4a
Zebrafish hoxd4a cDNA clones and PACs covering the hoxda cluster have been previously reported (Amores et al., 1998; Prince et al., 1998) . Sequence comparison between the zebrafish and mouse Hoxd4 loci reveals the conservation of several previously defined regulatory elements. These include a 5 0 RARE, an ARE, a transcriptional promoter (P1), a portion of the 5 0 untranslated region (UTR), a presumed intron enhancer (CR1), and a 3 0 RARE (Fig. 1A) . The arrangement, and spacing, between these elements is likewise conserved, although the intervening distance between the first coding exon and the P1 promoter is greater in zebrafish than in mouse (Fig. 1A) . Alignment of these regulatory elements reveals a high degree of nucleotide conservation (Fig. 1B) . For both RAREs, the sequence of the direct repeats is identical.
Furthermore, each contains a conserved non-consensus nucleotide substitution. In the 5 0 RARE, a non-consensus guanine nucleotide is found in the first direct repeat (bold text, Fig. 1B ), whereas a non-consensus adenosine nucleotide is present in the second direct repeat of the 3 0 RARE (bold text, Fig. 1B ). Several additional conserved blocks of homology are found to either side of the 5 0 and 3 0 RARE (sites A though F in Fig. 1B ). In addition to the RARE, site D is required to set the correct anterior expression border of Hoxd4 transgenes, and deletion of the region containing sites D, E and F abolishes transgene activity (Zhang et al., 2000) . These observations strongly support a role in neural enhancer function for these conserved elements. Large regions of sequence conservation occur in the ARE, the P1 promoter, and the 5 0 UTR. In the ARE, not only is the first Hox binding site (TAAT) identical, but it is flanked by several blocks of conserved sequence (Fig. 1B) . However, the second Hox binding site of the ARE (mouse: ATTA, zebrafish: TATA) and its flanking sequences are poorly conserved. In the P1 promoter, the ATGG transcriptional start sites (Folberg et al., 1997) are conserved. These are preceded by two long stretches of highly conserved sequence. Likewise, there are large blocks of conserved sequence preceding the translation start site of the Hoxd4 gene. These suggest that the factors involved in the initiation of transcription and translation of Hoxd4 have been highly conserved during evolution. Unlike the 5 0 UTR, the 3 0 UTR and the polyadenylation sequences are not extensively conserved between zebrafish and mouse (data not shown). In addition, only one polyadenylation sequence is recognizable in zebrafish, and this fails to align with either of two presumptive polyadenylation sequences in mouse. Although the size of the intron is different (mouse: 559 bp, zebrafish: 396 bp), there is a region of sequence conservation (Fig. 1B) . This region also shares sequence similarity to intron elements found in Hoxb4 (Aparicio et al., 1995) and Hoxa7 (Haerry and Gehring, 1996) . Alignment of six Hox introns shows that there are two blocks of sequence conservation. The first block is the consensus binding site for many homeodomain-containing proteins, and the second block is similar to the consensus binding site for the CDX homeoprotein (Fig. 1B ).
Sequences 3
0 to the mouse and zebrafish Hoxd4 genes display identical neural enhancer activities in transgenic mouse embryos
To determine whether sequence conservation with the mouse neural enhancer reflected conservation of function, a 570 bp zebrafish hoxd4a fragment encompassing sites A through F (Fig. 1A) was cloned in front of the rabbit bglobin promoter in the p1229 lacZ reporter and tested in transgenic mouse embryos. As shown in Fig. 4 , zebrafish sequences displayed neural enhancer activity identical to that of their murine counterpart Zhang et al., 1997) , setting the correct anterior border of expression in the hindbrain at r6/7.
The affinity of the RXR·RAR heterodimer is higher for a consensus RARE and lower for DR2 RAREs
The above results show that the function and sequence of a 3 0 neural enhancer has been conserved between Hoxd4 orthologs in zebrafish and mouse. An essential element of the murine enhancer is the 3 0 RARE. Two aspects of this element have been conserved. First, in both species the RARE is of the DR5 type, rather than DR2. Second, the sequence of the half-sites is perfectly conserved, including a nonconsensus substitution in the second half-site (Fig. 1B) . We asked whether the conservation of half-site spacing and nonconsensus substitution were important for setting the correct Hoxd4 anterior expression border at r6/7 in the embryonic hindbrain.
Experimental evidence supports the presence of an RA gradient in the hindbrain where the concentration is the highest at the hindbrain/spinal cord border and decreases towards the rostral hindbrain. The anterior borders of many of the earliest expressed Hox genes are located in the developing hindbrain. Since these expression borders can be anteriorized in response to endogenous RA, the setting of the anterior border may be a function of the gene's ability to 'read' the local concentration of RA. Several of these early expressed Hox genes have RAREs. In reporter transgene assays, RARE mutation either abolishes or posteriorizes expression in the neurectoderm. Furthermore, mutation of these RAREs attenuates the transgene's response to endogenous RA. Differences in the sequence and/or spacing of these RAREs may affect their affinity for the RXR·RAR heterodimers. Thus, the affinity of the heterodimer for the RARE could determine where the border is set in the hindbrain. We would predict that the RXR·RAR heterodimer would have greater affinity for RAREs of Hox genes with more anterior expression borders. This would be necessary to ensure that transactivation of the heterodimer could occur in regions of lower RA concentrations. To test this model, we determined the dissociation rates for the RXRa·RARa complex on several different RAREs by EMSAs (Fig. 2) .
We found that an RXRa·RARa heterodimer has a halflife of approximately 29 min on the wild type Hoxd4 3 0 RARE (Fig. 2, panel 1) . This was increased by almost 3 fold to 79 min when the non-consensus adenosine was converted to a consensus thymidine (hereafter referred to as the consensus RARE) (Fig. 2, panel 2) . When the wild type Hoxd4 DR5 RARE was converted to a DR2 element, the halflife for the RXRa·RARa heterodimer fell to 6 min (Fig. 2,  panel 3 ). Of the naturally occurring RAREs, the heterodimer had a half-life of 10 and 34 min for the Hoxb1 DR2 RARE and the Hoxa1 DR5 RARE, respectively (Fig. 2, panels 4 and 5). Thus, the dissociation data do not support the model since the half-lives of heterodimers binding to two RAREs that are associated with Hox genes having more anterior borders than Hoxd4 are shorter or comparable to the half-life of the heterodimer on the Hoxd4 RARE.
2.4. Changing the wild type Hoxd4 RARE for other RAREs cannot anteriorize expression beyond the r6/7 border Previously, the Hoxd4 neural enhancer was shown to drive expression of Hoxd4 in the embryonic CNS up to the correct r6/7 border in the hindbrain (Zhang et al., 2000) . In this earlier study, a 538 bp fragment containing the 3 0 RARE Fig. 2 . Dissociation rates of the RXRa·RARa heterodimer on RAREs of different sequence. Each EMSA was repeated three times using five time points: 0, 5, 10, 15, and 30 min. The Hoxa1 DR5 RARE was used as the cold competitor for all experiments. The wild type Hoxd4 DR5 3 0 RARE had a half-life of approximately 29 min (panel 1) whereas the Hoxa1 DR5 RARE had a comparable half-life of 34 min (panel 5). A single nucleotide substitution, converting the wild type Hoxd4 RARE to a consensus sequence, increased its half-life by 2.7 fold (panel 2). Alternatively, converting the Hoxd4 RARE to a DR2 element cripples its affinity for the heterodimer by almost 5 fold (panel 3). The naturally occurring Hoxb1 DR2 RARE had a slightly better affinity than the mutant Hoxd4 DR2 RARE with a calculated half-life of 10 min (panel 4). The sequence of the various RAREs is given in Fig. 3 .
was fused to a large reporter construct containing the endogenous Hoxd4 promoter within approximately 10 kb of genomic sequence (pSHlacZpA) (Zhang et al., 2000) . We tested the ability of this 538 bp region to drive transgene expression from a heterologous promoter. When the mouse neural enhancer is tested for its ability to direct transcription of the lacZ reporter fused to the rabbit b-globin minimal promoter (Fig. 3, construct #1 ), strong lacZ expression is seen in the CNS with the correct r6/7 border in the hindbrain (Fig. 4, #1 ). There is also b-galactosidase activity in a portion of the lateral plate mesoderm. Of the three expressors, this embryo displayed the strongest level of lacZ expression in the CNS even though its posterior domain of expression is absent. The other two embryos displayed lacZ expression only in the CNS with the correct anterior border. Although the CNS expression of these two embryos extended further posteriorly, the overall activity of the transgene was weaker probably due to the site of integration.
Since the anterior border of expression was correct for these three independently derived transgenics, we used this 538 bp region to test the ability of the RAREs assayed by EMSA to drive lacZ expression. The constructs tested are depicted in Fig. 3 . Constructs 2 through 5 differed only in the sequence of the RARE.
In two independently derived embryos, introducing the consensus RARE in place of the Hoxd4 3 0 RARE resulted in lacZ expression with the correct anterior border at r6/7 (Fig.  4, #2 ). The third embryo had weaker expression in the neural tube and its anterior border was slightly posteriorized with respect to wild type (data not shown). Therefore, increasing the affinity of the RXR·RAR heterodimer for the RARE does not anteriorize expression of the transgene beyond the r6/7 border. Changing the Hoxd4 RARE from a DR5 to a DR2 element by altering the spacer results in weaker lacZ expression with an anterior border that is posteriorized into the developing spinal column (Fig. 4, #3) . Introduction of the Hoxb1 DR2 RARE is even more Fig. 3 . Constructs tested in transient transgenic assays. Construct #1 contains the wild type Hoxd4 neural enhancer. Constructs #2 -#5 replace the wild type Hoxd4 RARE with other RAREs as indicated. Constructs #6 and #7 test RARE function in the context of the endogenous Hoxd4 promoter. In the p1229 vector, the lacZ sequence (blue rectangle) is fused to the b-globin minimal promoter (yellow square). The pSHlacZpA vector contains approximately 10 kb of Hoxd4 genomic sequence, with the lacZ coding sequence inserted in-frame into the first of two coding exons (clear boxes) (Zhang et al., 1997) . Neural enhancer derivatives were inserted 3 0 to the second coding exon. Vector features are not drawn to scale. 'Expression' indicates the fraction of embryos that expressed the transgene over the number of embryos bearing the transgene (as detected by PCR). 'Border' indicates the fraction of embryos with the correct r6/7 border over the total number of transgenic embryos. RARE half-sites are indicated by half-arrows above the sequence, and site D is overlined.
detrimental to the activity of the neural enhancer, almost entirely impairing transgene expression in the neural tube (Fig. 4, #4) . One possible reason why DR2 RAREs perform poorer in the transgenic assay than the DR5 RAREs may be that the stereoalignment of the bound RXR·RAR heterodimer with neighboring factors is altered by the internal deletion of three nucleotides. Consequently we generated another construct in which three additional nucleotides were inserted immediately downstream of the Hoxb1 DR2 RARE (construct #5). Such a change might have realigned a 3 0 -bound RAR with factors bound downstream. However, this change did not rescue neural enhancer activity (Fig. 4,  #5) . Therefore, in the context of the Hoxd4 neural enhancer, natural RAREs and artificially derived RAREs for which the heterodimer displayed different affinities could not anteriorize expression of lacZ beyond the r6/7 border. In fact, three out of four RARE substitutions resulted in weaker and posteriorized transgene expression.
The activity of the RARE is independent of the promoter used to drive lacZ expression
When comparing the ability of the neural enhancer to activate lacZ expression from the b-globin minimal promoter (p1229) against the endogenous Hoxd4 promoter (pSHlacZpA), we observed a difference in the fraction of embryos expressing the transgene. In the p1229 construct, 60% of the transgenic embryos express lacZ (Fig. 3, #1) , whereas in the pSHlacZpA construct, all transgenic embryos express the transgene (Zhang et al., 2000) . Moreover, removal of 35 bp from the 3 0 end of the neural enhancer (construct #8 in Zhang et al., 2000) still allowed it to display full neural activity in pSHlacZpA. This same construct was never expressed in p1229 (Nolte and Featherstone, unpublished data). Thus, the endogenous Hoxd4 promoter and/or upstream sequences appear to contribute to the overall activity of the neural enhancer. Therefore, we tested if the consensus RARE could anteriorize expression when placed under the control of endogenous Hoxd4 promoter and additional enhancer sequences (construct #6). In the context of this transgene, the consensus RARE is still unable to anteriorize lacZ expression beyond the r6/7 border (Fig. 4, #6 ).
The consensus RARE cannot rescue the posteriorizing effect of a mutant neural enhancer
Conversion of the Hoxd4 RARE to a higher affinity consensus element did not augment or anteriorize neural enhancer activity in association with heterologous or natural promoters. We therefore asked whether the 'high affinity' consensus RARE could compensate for the loss of adjacent elements. Previously, we showed that mutation of site D (Fig. 1B , originally noted as a potential CDX binding site) posteriorized transgene expression, especially in the ventral hindbrain (Zhang et al., 2000) . This same site D mutation was incorporated into a Hoxd4 neural enhancer bearing a consensus RARE and tested in transgenic embryos (Fig. 3,  construct #7 ). Three independently derived embryos expressed this construct. In one embryo, expression of construct #7 was anteriorized within the neural tube but failed to reach the r6/7 border, while in the remaining two embryos, the border remained posteriorized (Fig. 4, #7) . Therefore, changing heterodimer affinity by replacing the wild type RARE with the consensus RARE cannot compensate for the mutation of an adjacent site important for neural expression.
Discussion
In this study, we show that the sequences of several Hoxd4 regulatory elements are conserved between mouse and zebrafish. These include two RAREs, a transcriptional promoter (P1), a presumptive intron enhancer, and an ARE. Of these elements, we explored the importance of the conserved 3 0 RARE in setting the anterior border of Hoxd4 expression in the hindbrain. We find that changes to the sequence or spacing of the RARE cannot anteriorize Hoxd4 expression beyond its normal r6/7 border.
In addition to these elements, we find highly conserved stretches of DNA sequence preceding the start sites of transcription and translation. Although the relevance of these conserved regions is not known, we speculate that they are important for the regulation of these processes. An alignment of the 5 0 UTR sequences from zebrafish hoxd4a and mouse Hoxd4, Hoxa4, Hoxb4, Hoxc4, and Hoxb1 reveals that the large blocks of sequence conservation are specific for the Hoxd4 5 0 UTR (data not shown). This suggests that factors recruited for Hoxd4 translation may be different among the group 4 paralogs and other Hox members. Unfortunately, we cannot perform an alignment of different Hox promoters since this information is not readily available. However, one reason for this high level of sequence conservation preceding the promoter may be to recruit factors involved in local chromatin remodeling or histone repositioning to allow access to the transcriptional machinery (Gilthorpe et al., 2002) .
Compared to the long stretches of conserved sequence preceding the transcription and translation start sites, the ARE shows only partial sequence conservation. In particular, the sequence in and around the second HOX binding site is poorly conserved. This suggests that this region is not as important in autoregulation as the first TAAT element, although for the murine Hoxd4 gene both TAAT motifs are required for maximal reporter activity in P19 cells (Pöpperl and Featherstone, 1992) . For the fly Deformed gene, an ortholog of Hoxd4, four ATTA motifs are required for promoting expression in the maxillary segments (Regulski et al., 1991) . Zebrafish may compensate for the loss of one HOX binding site with several upstream TAAT/ATTA motifs not conserved in the mouse (data not shown). Transgenic analysis of the zebrafish 5 0 sequences would help delineate the bounds of the zebrafish ARE which could be further tested in mouse mutants lacking fourth group genes.
The zebrafish hoxd4a neural enhancer functions in a mouse transgenic assay in a manner identical to the murine enhancer. Consistent with this, the sequence of the 3 0 RARE within the neural enhancer, plus six flanking sites (A through F), are conserved between the two species. In addition to the 3 0 RARE, the region containing conserved sites D, E and F is absolutely required for Hoxd4 neural enhancer function, and mutation of site D causes a marked posteriorization of enhancer activity (Zhang et al., 2000) . These results strongly support a role for these conserved elements in the recruitment of essential transcriptional regulators, and validates such phylogenetic footprinting approaches for the identification of cis-acting elements (Gumucio et al., 1992; Müller et al., 2002) .
Since the mouse 3 0 RARE is important for Hoxd4 neural expression and the function of the zebrafish neural enhancer is conserved, we asked what is the significance of the RARE sequence and spacing between the half-sites in neural expression. As introduced earlier, the juxtaposition of RAdegrading and RA-producing domains within and flanking the developing hindbrain suggests that an RA gradient is established across this region. This gradient could specify the expression domains of Hox genes through induction at different threshold concentrations of RA. Thus, the sequence and spacing of the Hox RAREs may differentially affect heterodimer affinity. According to this model, more anteriorly expressed genes would require that the RXR·RAR heterodimer have greater affinity for their RAREs to compensate for reduced ligand availability. To test our theory, we performed dissociation rate determinations on different RARE-receptor complexes, and tested these RAREs in the context of the Hoxd4 neural enhancer for their ability to drive CNS expression. Contrary to the model, the heterodimer affinity for RAREs of more anteriorly expressed genes was equal to, or less than, the Hoxd4 RARE. In addition, none of the tested RAREs could anteriorize transgene expression beyond the r6/7 border when placed in the context of the Hoxd4 neural enhancer.
The sequence of the Hoxd4 RARE deviates from the consensus by one nucleotide, whereas the sequence of the Hoxa1 RARE matches the consensus. However, the affinity of the RXRa·RARa heterodimer for both is comparable. Furthermore, converting the Hoxd4 RARE to the consensus increases the DNA-heterodimer complex stability by 3 fold.
The difference in the half-lives of the RXRa·RARa heterodimer bound to these two 'consensus' RAREs may reflect preferences for different combinations of retinoid receptors that form the RXR·RAR heterodimer. For example, in F9 cells lacking one or more of the retinoid receptors, the RA responsiveness of the Hoxa1 gene was greatest with the RXRa·RARg heterodimer, while that of the Hoxb1 was mediated by the RXRa·RARa or RXRa·R-ARg heterodimers (Chiba et al., 1997) . This preference may be determined by the third nucleotide of the second direct repeat. In the Hoxa1 RARE this nucleotide is a thymidine (AGTTCA) whereas it is a guanine in both the consensus (AGGTCA) and Hoxd4 (AGGACA) RAREs. Therefore, RARa could have greater stability on a repeat in which a guanine occupies this position rather than a thymidine. In steady-state EMSAs, both full length RARa and its DNAbinding domain alone display greater monomeric and dimeric binding on DRs composed of PuGGTCA rather than PuGTTCA (Fig. 1) (Mader et al., 1993) . Nevertheless, despite a greater affinity for the RXRa·RARa heterodimer, the consensus RARE did not anteriorize lacZ expression from either a minimal b-globin promoter or the Hoxd4 promoter, nor could it rescue the posteriorizing effect of a mutation in the neighboring site D.
The inability of the high-affinity consensus RARE to anteriorize lacZ expression is consistent with a similar inability of other RAREs. Thus, converting the Hoxd4 RARE into a DR2 element or exchanging it for the Hoxb1 DR2 RARE does not anteriorize expression. Instead, these lower affinity RAREs result in weakened and posteriorized lacZ expression. These results differ from the observation that the substitution of the DR5 RARE of the Hoxb4 neural enhancer with the Hoxb1 DR2 RARE anteriorized transgene expression up to the Hoxb1 r3/4 border (Gould et al., 1998) . However, these two neural enhancers display clear mechanistic differences. Not only is there little sequence conservation in the regions flanking the Hoxb4 and Hoxd4 RAREs (data not shown), but neural expression of Hoxb4 requires the input of two enhancers (Gould et al., 1998) . The 'early' neural enhancer containing the Hoxb4 RARE cannot set the correct anterior border of a lacZ transgene at r6/7. It requires in addition a 'late' neural enhancer that lies upstream of the early neural enhancer (Gould et al., 1998) . This 'late' neural enhancer is conserved between mouse and pufferfish (Aparicio et al., 1995) and contains a PBX·HOX DNA motif . We have no evidence that a similar mechanism has been conserved for neural expression of the Hoxd4 gene. A search of the Hoxd4 gene between the end of the second coding exon and the 3 0 RARE reveals only one potential PBX·HOX binding site, however it is not conserved between mouse and zebrafish. Consequently, it appears that the mechanisms for setting the anterior border at r6/7 have diverged between Hoxb4 and Hoxd4. The activity of the late neural enhancer may be regulated by HOXD4 since our laboratory has observed cooperative DNA-binding of a PBX·HOXD4 heterodimer on the Hoxb4 late neural enhancer (K. Shanmugam and M.F., unpublished data). This implies that there is a hierarchy in which Hoxb4 expression is initiated by its early enhancer but fine-tuned to the r6/7 border by its late enhancer. Consequently, the setting of the Hoxd4 anterior border could be more stringently controlled because its product is required to set the correct Hoxb4 border. This may be analogous to the role of Hoxa1 in setting the correct expression border of its paralog Hoxb1 (Barrow et al., 2000) .
Since mutation of the neighboring site D or deletion of all sequence downstream of the Hoxd4 RARE posteriorizes or abolishes neural expression (Zhang et al., 2000) , the factors that bind to these sites may interact synergistically or additively with the RXR·RAR heterodimer to set the correct border of expression at r6/7. Compromising the affinity of any of the factors for these sites (i.e. by mutating their sequences) decreases the overall strength of the enhancer and results in posteriorized expression of the reporter. Taken together, these data demonstrate that the Hoxd4 RARE is just one part of a larger cis-acting region that sets that anterior border of Hoxd4 expression in the hindbrain.
Experimental procedures

Cloning and sequencing of zebrafish hoxd4a sequences
A zebrafish PAC clone containing a 150 kb region of the zebrafish hoxda cluster (Amores et al., 1998) , and several zebrafish hoxd4a cDNAs were isolated. A zebrafish hoxd4a cDNA hybridized to two BamHI fragments on a Southern blot of the zebrafish PAC clone. Both BamHI fragments were cloned into pBluescript (Stratagene). The first BamHI clone (, 4.5 kb) included the 5 0 region of the zebrafish hoxd4a gene as well as a small portion of the first coding exon. The second BamHI clone (5.8 kb) included the remaining portion of the first coding exon, the intron, the second coding exon containing the homeobox, and a large 3 0 region (Fig. 1A) . Smaller HindIII subclones were derived from both BamHI clones. Sequencing was accomplished by manual (T7 Sequencing Kit, USB) and automated approaches (Visible Genetics System). The sequence of the zebrafish hoxd4a genomic locus has been deposited with GenBank (accession number AY168642).
Half-life determination by electrophoretic mobility shift assays (EMSAs)
Oligonucleotide probes were prepared as described (Phelan and Featherstone, 1997 Each dissociation rate determination covered five time points: 0, 5, 10, 15, and 30 min. Prior to the addition of cold competitor, labeled double-stranded oligonucleotides were incubated for 40 min at room temperature along with in vitro translated RARa and RXRa (TnT coupled kit, Promega), poly dIdC (40 ng/reaction), and buffer (1 M NaCl, 200 mM Tris (pH 7.5), 200 mM DTT, 100 mM EDTA, BSA, 10% glycerol). The first time point was loaded immediately following the addition and mixing of cold competitor, and subsequent time points were loaded accordingly.
In all RXRa·RARa dissociation rate determinations, the cold competitor was the Hoxa1 RARE which was added at a final concentration of 170 pmol per lane. Approximately 130 fmol of labeled probe was loaded per lane. Determination of half-lives of the RXRa·RARa heterodimer for the different RAREs was as previously described (Green et al., 1998) .
Transgene constructs
The RAREs used in the dissociation rate determination were used to replace the Hoxd4 RARE of the mouse neural enhancer by PCR overlap extension (Ho et al., 1989) . These constructs (#1 to #5, Fig. 3) were subcloned into the HindIII-XhoI site of the p1229 vector (gift of Robb Krumlauf). This vector contains the lacZ coding sequence fused to a minimal b-globin promoter. Additional transgene constructs (#6 to #8, Fig. 3) were cloned using the strategy described by Zhang et al. (2000) . All clones were confirmed by manual sequencing.
Production of transgenic mice
Transgenes were separated from their vector backbones by restriction endonuclease digestion gel purification using the Qiaex II band purification kit (Qiagen) with the following modifications. 1.2% agarose gel was stained with 0.02% Methylene Blue (in 1 £ TAE buffer) for 15 min to visualize the DNA. The gel was quickly rinsed with several washes of 1 £ TAE before excising the appropriate fragment. Three or more washes of PE buffer were performed, of the recommended two, to remove residual Methylene Blue stain from the pellet.
All transgenes were dissolved in injection buffer (5 mM Tris (pH 7.4), 0.1 mM EDTA) and stored at 2 20 8C. On the day of microinjection, the transgene stock was diluted in injection buffer to a final concentration of 1 -2 ng/ml. This working stock was centrifuged for 10 min at 14000 rev./min to remove particulate matter. The top two-thirds of the supernatant was taken for microinjection. Microinjection needles were backfilled by capillary action at room temperature using Kwik-Fil microfilaments (World Precision Instruments). Generally, embryos were implanted in CD1 (Harlan) pseudopregnant fosters on the day of microinjection.
4.5. Collection of embryos for b-galactosidase staining CD1 fosters were sacrificed and embryos harvested 10 days after implantation. Yolk sacs were collected for transgene detection by PCR, and embryos were fixed and stained as described by Zhang et al. (1997) .
